Page 9 - Microsoft Word - 6942_BPR_Epub

CUAJ – CUA Best Practice Report Guo et al
BPL: AML management

17. Huang KH, Huang CY, Chung SD, Pu YS, Shun CT, Chen J. Malignant epithelioid
angiomyolipoma of the kidney. J Formos Med Assoc. 2007;106(2 Suppl):S51-S54.
doi:10.1016/s0929-6646(09)60353-3
18. Kim JK, Kim SH, Jang YJ, et al. Renal angiomyolipoma with minimal fat: differentiation from
other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology.
2006;239(1):174‐180. doi:10.1148/radiol.2391050102
19. Song S, Park BK, Park JJ. New radiologic classification of renal angiomyolipomas. Eur J Radiol.
2016;85(10):1835‐1842. doi:10.1016/j.ejrad.2016.08.012
20. Lin CY, Yang CK, Ou YC, et al. Long-term outcome of robotic partial nephrectomy for renal
angiomyolipoma. Asian J Surg. 2018;41(2):187-191. doi:10.1016/j.asjsur.2016.11.003
21. Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI. Renal epithelioid angiomyolipoma
with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of
malignancy. Am J Surg Pathol. 2010;34(5):715-722. doi:10.1097/PAS.0b013e3181d90370
22. Lee W, Choi SY, Lee C, et al. Does epithelioid angiomyolipoma have poorer prognosis,
compared with classic angiomyolipoma?. Investig Clin Urol. 2018;59(6):357-362.
doi:10.4111/icu.2018.59.6.357
23. Varma S, Gupta S, Talwar J, Forte F, Dhar M. Renal epithelioid angiomyolipoma: a malignant
disease. J Nephrol. 2011;24(1):18-22. doi:10.5301/jn.2010.5451
24. Marconi L, Dabestani S, Lam TB, et al. Systematic Review and Meta-analysis of Diagnostic
Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol. 2016;69(4):660‐673.
doi:10.1016/j.eururo.2015.07.072
25. Zhou H, Guo M, Gong Y. Challenge of FNA diagnosis of angiomyolipoma: A study of 33
cases. Cancer Cytopathol. 2017;125(4):257-266. doi:10.1002/cncy.21824
26. Kassouf W, Monteiro LL, Drachenberg DE, et al. Canadian Urological Association guideline for
followup of patients after treatment of non-metastatic renal cell carcinoma. Can Urol Assoc J.
2018;12(8):231-238. doi:10.5489/cuaj.5462
27. Cibas ES, Goss GA, Kulke MH, Demetri GD, Fletcher CD. Malignant epithelioid
angiomyolipoma ('sarcoma ex angiomyolipoma') of the kidney: a case report and review of the
literature. Am J Surg Pathol. 2001;25(1):121-126. doi:10.1097/00000478-200101000-00014
28. Kohno J, Matsui Y, Yamasaki T, et al. Role of mammalian target of rapamycin inhibitor in the
treatment of metastatic epithelioid angiomyolipoma: a case report. Int J Urol. 2013;20(9):938-
941. doi:10.1111/iju.12095
29. Maclean DF, Sultana R, Radwan R, McKnight L, Khastgir J. Is the follow-up of small renal
angiomyolipomas a necessary precaution?. Clin Radiol. 2014;69(8):822‐826.
doi:10.1016/j.crad.2014.03.016
30. Ouzaid I, Autorino R, Fatica R, et al. Active surveillance for renal angiomyolipoma: outcomes
and factors predictive of delayed intervention. BJU Int. 2014;114(3):412‐417.
doi:10.1111/bju.12604
31. Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K. Renal
angiomyolipoma: relationships between tumor size, aneurysm formation, and
rupture. Radiology. 2002;225(1):78‐82. doi:10.1148/radiol.2251011477
32. Swärd J, Henrikson O, Lyrdal D, Peeker R, Lundstam S. Renal angiomyolipoma-patient
characteristics and treatment with focus on active surveillance. Scand J Urol. 2020;54(2):141-
146. doi:10.1080/21681805.2020.1716066